tiprankstipranks
Bioxcel Therapeutics Inc (BTAI)
NASDAQ:BTAI
Holding BTAI?
Track your performance easily

Bioxcel Therapeutics (BTAI) Income Statement

1,340 Followers

Bioxcel Therapeutics Income Statement

Last quarter (Q3 2024), Bioxcel Therapeutics's total revenue was $214.00K, a decrease of -37.24% from the same quarter last year. In Q3, Bioxcel Therapeutics's net income was $-13.65M. See Bioxcel Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.28M$ 1.38M$ 375.00K---
Cost of Revenue
$ 2.02M$ 1.26M$ 20.00K---
Gross Profit
$ 251.00K$ 120.00K$ 355.00K---
Operating Expense
$ 74.47M$ 167.74M$ 160.00M$ 106.94M$ 82.30M$ -33.60M
Operating Income
$ -76.63M$ -171.78M$ -159.65M$ -106.94M$ -82.30M$ -33.60M
Net Non Operating Interest Income Expense
$ -3.86M$ -7.67M$ -5.68M$ 4.00K$ 128.00K$ -20.00K
Other Income Expense
$ -16.98M$ -3.77M$ -427.00K---
Pretax Income
$ -63.51M$ -179.05M$ -165.76M$ -106.93M$ -82.17M$ -32.97M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -71.00M$ -179.05M$ -165.76M$ -106.93M$ -82.17M$ -32.97M
Basic EPS
$ -2.16$ -6.15$ -5.92$ -4.05$ -3.79-
Diluted EPS
$ -2.16$ -6.15$ -5.92$ -4.05$ -3.79$ -2.02
Basic Average Shares
$ 142.96M$ 29.13M$ 28.02M$ 26.37M$ 21.68M$ 16.29M
Diluted Average Shares
$ 171.54M$ 29.13M$ 28.02M$ 26.37M-$ 16.32M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 76.49M$ 169.00M$ 160.02M$ 106.94M$ 82.30M$ -33.60M
Net Income From Continuing And Discontinued Operation
$ -71.00M$ -179.05M$ -165.76M$ -106.93M$ -82.17M$ -32.97M
Normalized Income
$ -54.14M$ -135.42M----
Interest Expense
------
EBIT
$ -56.67M$ -165.74M$ -157.54M$ -106.89M$ -82.14M$ -32.95M
EBITDA
$ -55.88M$ -165.42M$ -157.22M$ -106.59M$ -81.95M$ -32.79M
Currency in USD

Bioxcel Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis